BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001 | Psychedelic Invest
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders,